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Supplemental Figure 1.  Basal Cardiac Morphology and Hemodynamics in WT and Sestrin2 KO (Sesn2 
KO) Hearts.  (A) Heart weights and heart weight as a percentage of body weight comparing WT and 
Sestrin2 KO hearts (upper). Light microscopy of H&E stained heart tissue sections demonstrating no 
apparent structural differences in WT and Sestrin2 KO hearts (lower).  (B) In vivo pressure-volume 
relationships of WT and Sestrin2 KO hearts demonstrating similar hemodynamic properties (upper).  
Heart rate, cardiac output, and ejection fraction measurements from WT and Sestrin2 KO hearts indicate 
no major differences in cardiac function (lower).  n=4-6 per group 
	
	
	
	
	
	
 
 
Supplemental Figure 2.  (A) Immunoblots of LKB1, MO25, STRAD and GAPDH in WT and Sesn2 KO 
hearts under basal conditions.  (B) Immunoblot of CaMKKβ from Sestrin2 immune-complexes. Brain 
tissue was used as a positive control for CaMKKβ detection. 
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Supplemental Figure 3.  (A) Immunoblots of p-AMPK (Thr172), AMPK, and Sestrin2 in HeLa cells 
exposed to normoxic (95% air, 5% CO2) or hypoxic (95% N2, 5% CO2) conditions.  (B) Immunoblots of p-
AMPK (Thr172), AMPK, and Sestrin2 in HL-1 cardiomyocytes cells exposed to normoxic or hypoxic 
conditions. 
 
 
 
 
 
 
 
 
 
 
 
 
Supplemental Figure 4.  Effects of AMP on Sestrin2-induced AMPK Phosphorylation.  (A) Immunoblots 
of p-AMPK (Thr172) and AMPK from cardiomyocytes isolated from WT and Sesn2 KO hearts treated 
with either vehicle or AICAR (1 mM). Bar graphs show the quantification of AMPK phosphorylation 
relative to the amount of total AMPK and is expressed as a percentage of vehicle treatment.  (B) 
Immunoblots of p-AMPK (Thr172) and AMPK from HeLa cells treated with either vehicle or AICAR (1 
mM).  Bar graphs show the quantification of AMPK phosphorylation relative to the amount of total AMPK 
and is expressed as a percentage of vehicle treatment.  Values are means  SEM; *p<0.05 vs. vehicle; 
n=3 per group. 
